Michael Riha

Proteros biostructures GmbH is a holding company which serves as a discovery service business. Its business areas are Discovery Pipeline, Discovery Services and Science & Technology. The Discovery Pipeline focuses on protein biochemistry, X-ray crystallography, biophysics, computational chemistry and property driven medicinal chemistry, Discovery Services offers drug discovery services with expertise and proprietary technologies for protein production, protein structure analysis, kinetic and thermodynamic profiling and Science & Technology segment focuses on industrialized structure-guided lead development infrastructure. The company was founded by Robert Huber and Torsten Neuefeind in 1999 and is headquartered in Martinsried, Germany.

Part of Eurofins Scientific SE, Eurofins Genomics Europe Synthesis GmbH engages in research and development services. The company is based in Ebersberg, Germany. The CEOs of the German company are Peter Persigehl, Mandy Deimel, Sonja Wiedemann.

Part of Eurofins Scientific SE, Eurofins Genomics Europe Sequencing GmbH provides technical, physical and chemical analysis services. The company is based in Konstanz, Germany. The CEOs are Andreas Hinkel, Thomas Brefort. The German company was founded in 2018.

EDG Deutschland Holding GmbH is a leading dental and dental technology community with a focus on providing the best patient treatment. The private company is based in Hamburg, Germany. The CEOs are Michael Thorwarth, Christian Minz, Tobias Kiesewetter. The German company was founded in 2017.

Part of Eurofins Scientific SE, Eurofins GSC Management Services NV provides business management consulting services. The company is based in Auderghem, Belgium. The Belgian company was founded in 2001. The CEO is Gilles Martin.

Part of Eurofins Scientific SE, Eurofins Genomics Germany GmbH is a leading genomics services provider worldwide. The company is based in Ebersberg, Germany. Eurofins Genomics offers various platforms for genotyping, as well as genomic services such as NGS, gene expression, sanger sequencing, oligonucleotides, and gene synthesis. The German company also provides biomarker discovery services for disease diagnostics and therapeutic targets. Eurofins Genomics also offers SARS-CoV-2 research support. The company was founded in 1990, and Michael Hadem has been the CEO of the company since 2016.